Deficits in human trisomy 21 iPSCs and neurons
Open accessAbstract
Down syndrome (trisomy 21) is the most common genetic cause of intellectual disability, but the precise molecular mechanisms underlying impaired cognition remain unclear. Elucidation of these mechanisms has been hindered by the lack of a model system that contains full trisomy of chromosome 21 (Ts21) in a human genome that enables normal gene regulation. To overcome this limitation, we created Ts21-induced pluripotent stem cells (iPSCs) from two sets of Ts21 human fibroblasts. One of the fibroblast lines had low level mosaicism for Ts21 and yielded Ts21 iPSCs and an isogenic control that is disomic for human chromosome 21 (HSA21). Differentiation of all Ts21 iPSCs yielded similar numbers of neurons expressing markers characteristic of dorsal forebrain neurons that were functionally similar to controls. Expression profiling of Ts21 iPSCs and their neuronal derivatives revealed changes in HSA21 genes consistent with the presence of 50% more genetic material as well as changes in non-HSA21 genes that suggested compensatory responses to oxidative stress. Ts21 neurons displayed reduced synaptic activity, affecting excitatory and inhibitory synapses equally. Thus, Ts21 iPSCs and neurons display unique developmental defects that are consistent with cognitive deficits in individuals with Down syndrome and may enable discovery of the underlying causes of and treatments for this disorder.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Results from induced pluripotent stem cell studies of neurogenesis are discordant: the generation of neurons from induced pluripotent stem cells has been reported in some studies to be impaired and in others not to be impaired, which may be explained by technical differences in the cell lines and protocols used.
“However, results from these studies are discordant: the generation of neurons from iPSCs has been reported in some studies to be impaired74,77–79 and in others not to be impaired75,80,81, which may be explained by technical differences in the cell lines and protocols used (see Box 1).”
From Consequences of trisomy 21 for brain development in Down syndrome (2024) · cites this paper as [81]
Analyses of neural progenitor cells arising from trisomy 21 induced pluripotent stem cells have provided conflicting data, with some suggesting that apoptosis is increased and others seeing no effect.
“Analyses of NPCs arising from T21 iPSCs have provided conflicting data, with some suggesting that apoptosis is increased74,79,95 and others seeing no effect75,77,81,96.”
From Consequences of trisomy 21 for brain development in Down syndrome (2024) · cites this paper as [81]
In T21 iPSC-derived neurons, the proportion of inhibitory to excitatory synaptic transmission does not differ from controls, contrary to findings in mouse models of DS.
“However, the proportion of inhibitory to excitatory synaptic transmission, as assessed by the number of inhibitory post-synaptic currents relative to the number of excitatory post-synaptic currents detected using whole-cell voltage clamp, does not differ between control and T21 iPSC-derived neurons, contrary to findings in mouse models of DS81.”
From Consequences of trisomy 21 for brain development in Down syndrome (2024) · cites this paper as [81]
In vitro human iPSC-derived neurons from individuals with DS have reduced excitatory synaptic density relative to controls and functional deficits in excitatory synaptic transmission, including reduced frequency of spontaneous post-synaptic currents.
“In vitro data from human iPSC-derived neurons indicate that neurons from humans with DS not only have reduced excitatory synaptic density relative to controls but also exhibit functional deficits in excitatory synaptic transmission, including reduced frequency of spontaneous post-synaptic currents81,131.”
From Consequences of trisomy 21 for brain development in Down syndrome (2024) · cites this paper as [81]
Genome-wide dysregulation of gene expression in neurons likely leads to over-expression and/or under-expression of key genes that regulate synaptogenesis.
“Genome-wide dysregulation of gene expression (Box 3) in neurons likely leads to over-expression and/or under-expression of key genes that regulate synaptogenesis, but specific candidates have yet to be identified74,77,81,143.”
From Consequences of trisomy 21 for brain development in Down syndrome (2024) · cites this paper as [81]
Trisomic iPSC-derived early cortical neurons show decreased synapsin positive puncta and decreased incidence/frequency of spontaneous post synaptic currents.
“Recapitulating this finding, a study of iPSC derived early cortical neurons identified a decrease in synapsin positive puncta as well as a decrease in the incidence and frequency of spontaneous post synaptic currents, indicating deficits in the ability to form functional synaptic connections in trisomic neurons (Weick et al., 2013).”
From Neurodevelopment in Down syndrome: Concordance in humans and models (2022) · cites this paper as Weick et al., 2013
Two studies found no changes in differentiation of excitatory cortical neurons from trisomic iPSCs.
“Two studies using isogenic pairs of iPSCs did not identify any changes in differentiation of excitatory cortical neurons (Weick et al., 2013; Murray et al., 2015).”
From Neurodevelopment in Down syndrome: Concordance in humans and models (2022) · cites this paper as Weick et al., 2013
No change in electrical properties of trisomic early cortical neurons.
“One study found no change in the electrical properties of either excitatory or inhibitory trisomic early cortical neurons indicating that at that stage, there is no difference in intrinsic ability to communicate (Weick et al., 2013).”
From Neurodevelopment in Down syndrome: Concordance in humans and models (2022) · cites this paper as Weick et al., 2013
Cites
Pax6 is a human neuroectoderm cell fate determinant
Zhang, X., Huang, C. T., Chen, J., Pankratz, M. T., Xi, J., Li, J., Yang, Y., LaVaute, T. M., Li, X.-J., Ayala, M., et al. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.04.017 · Cited by 480 · see citing works
Self-citationDown's syndrome: Is there a decreased population of neurons?
Ross, M. H., Galaburda, A. M., & Kemper, T. L. (1984) · Neurology · doi:10.1212/wnl.34.7.909 · Cited by 191 · see citing works
Transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regions
Sturgeon, X., & Gardiner, K. J. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9321-y · Cited by 117 · see citing works
ets-2 Promotes the Activation of a Mitochondrial Death Pathway in Down's Syndrome Neurons
Helguera, P., Pelsman, A., Pigino, G., Wolvetang, E., Head, E., & Busciglio, J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5107-04.2005 · Cited by 88 · see citing works
Reduced cell number in the neocortical part of the human fetal brain in Down syndrome
Larsen, K. B., Laursen, H., Græm, N., Samuelsen, G. B., Bogdanovic, N., & Pakkenberg, B. (2008) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2008.05.007 · Cited by 87 · see citing works
Evidence of Arrest of Neurogenesis and Synaptogenesis in Brains of Patients with Down's Syndrome
(1984) · New England Journal of Medicine · doi:10.1056/nejm198411013111819 · Cited by 82 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Neural Subtype Specification from Human Pluripotent Stem Cells
Tao, Y., & Zhang, S.-C. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.10.015 · Cited by 287 · see citing works
Self-citationChen, C., Jiang, P., Xue, H., Peterson, S. E., Tran, H. T., McCann, A. E., Parast, M. M., Li, S., Pleasure, D. E., Laurent, L. C., et al. (2014) · Nature Communications · doi:10.1038/ncomms5430 · Cited by 219 · see citing works
Self-citationXu, R., Brawner, A. T., Li, S., Liu, J.-J., Kim, H., Xue, H., Pang, Z. P., Kim, W.-Y., Hart, R. P., Liu, Y., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.04.014 · Cited by 193 · see citing works
Self-citationTang, X.-Y., Xu, L., Wang, J., Hong, Y., Wang, Y., Zhu, Q., Wang, D., Zhang, X.-Y., Liu, C.-Y., Fang, K.-H., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci135763 · Cited by 143 · see citing works
Self-citationHuo, H.-Q., Qu, Z.-Y., Yuan, F., Ma, L., Yao, L., Xu, M., Hu, Y., Ji, J., Bhattacharyya, A., Zhang, S.-C., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.02.001 · Cited by 122 · see citing works
Self-citationIn vivo modeling of human neuron dynamics and Down syndrome
Real, R., Peter, M., Trabalza, A., Khan, S., Smith, M. A., Dopp, J., Barnes, S. J., Momoh, A., Strano, A., Volpi, E., et al. (2018) · Science · doi:10.1126/science.aau1810 · Cited by 120 · see citing works
iPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter?
Scesa, G., Adami, R., & Bottai, D. (2021) · Cells · doi:10.3390/cells10061470 · Cited by 110 · see citing works
Thinking out of the dish: what to learn about cortical development using pluripotent stem cells
van den Ameele, J., Tiberi, L., Vanderhaeghen, P., & Espuny-Camacho, I. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.03.005 · Cited by 110 · see citing works
Down-syndrome-induced senescence disrupts the nuclear architecture of neural progenitors
Meharena, H. S., Marco, A., Dileep, V., Lockshin, E. R., Akatsu, G. Y., Mullahoo, J., Watson, L. A., Ko, T., Guerin, L. N., Abdurrob, F., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2021.12.002 · Cited by 92 · see citing works
Integrated Quantitative Transcriptome Maps of Human Trisomy 21 Tissues and Cells
Pelleri, M. C., Cattani, C., Vitale, L., Antonaros, F., Strippoli, P., Locatelli, C., Cocchi, G., Piovesan, A., & Caracausi, M. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00125 · Cited by 61 · see citing works
Mizuno, G. O., Wang, Y., Shi, G., Wang, Y., Sun, J., Papadopoulos, S., Broussard, G. J., Unger, E. K., Deng, W., Weick, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.033 · Cited by 58 · see citing works
Self-citationNeurodevelopment in Down syndrome: Concordance in humans and models
Klein, J. A., & Haydar, T. F. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.941855 · Cited by 47 · see citing works
“One study found no change in the electrical properties of either excitatory or inhibitory trisomic early cortical neurons indicating that at that stage, there is no difference in intrinsic ability to communicate (Weick et al., 2013).”
BackgroundResultGonzales, P. K., Roberts, C. M., Fonte, V., Jacobsen, C., Stein, G. H., & Link, C. D. (2018) · PLOS ONE · doi:10.1371/journal.pone.0194581 · Cited by 45 · see citing works
Astrocytes in Down Syndrome Across the Lifespan
Ponroy Bally, B., & Murai, K. K. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.702685 · Cited by 35 · see citing works
Consequences of trisomy 21 for brain development in Down syndrome
Russo, M. L., Sousa, A. M. M., & Bhattacharyya, A. (2024) · Nature Reviews Neuroscience · doi:10.1038/s41583-024-00866-2 · Cited by 28 · see citing works
“Genome-wide dysregulation of gene expression (Box 3) in neurons likely leads to over-expression and/or under-expression of key genes that regulate synaptogenesis, but specific candidates have yet to be identified 74,77,81,143 .”
InfluentialSelf-citationPlasticity of Synaptic Transmission in Human Stem Cell-Derived Neural Networks
Dong, Y., Xiong, M., Chen, Y., Tao, Y., Li, X., Bhattacharyya, A., & Zhang, S.-C. (2020) · iScience · doi:10.1016/j.isci.2020.100829 · Cited by 19 · see citing works
Self-citationBiphasic cell cycle defect causes impaired neurogenesis in down syndrome
Sharma, V., Nehra, S., Do, L. H., Ghosh, A., Deshpande, A. J., & Singhal, N. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1007519 · Cited by 14 · see citing works
Qiu, J.-J., Liu, Y.-N., Wei, H., Zeng, F., & Yan, J.-B. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1137123 · Cited by 12 · see citing works
Self-citationIshihara, K. (2021) · Genes · doi:10.3390/genes12101598 · Cited by 8 · see citing works
- Authors
- Weick, J. P., Held, D. L., Bonadurer, G. F., Doers, M. E., Liu, Y., Maguire, C., Clark, A., Knackert, J. A., Molinarolo, K., Musser, M., Yao, L., Yin, Y., Lu, J., Zhang, X., Zhang, S.-C., & Bhattacharyya, A.
- Affiliations
- Waisman Center,
- University of Wisconsin–Madison (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-05-28
- Volume
- 110
- Issue
- 24
- Pages
- 9962-9967
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3683748
- OpenAlex
- W2021800885
- Cited by
- 205
- References
- 6
- Citations by year
- 2026: 12 · 2025: 14 · 2024: 18 · 2023: 21 · 2022: 17 · 2021: 14 · 2020: 15 · 2019: 16 · 2018: 20 · 2017: 13 · 2016: 9 · 2015: 17 · 2014: 15 · 2013: 4
- FWCI
- 15.30
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- other-oa
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS045926)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R21HD060134, P30HD03352., R21HD085288, P30HD003352)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Keywords
- Down syndrome, induced pluripotent stem cells, iPSC-derived neurons, intellectual disability, synaptic activity, oxidative stress, compensatory gene expression, mosaicism, isogenic controls, cognitive impairment, iPSC differentiation
- MeSH terms
- Cell Differentiation, Cells, Cultured, Chromosomes, Human, Pair 21, Down Syndrome, Fibroblasts, Genotype, Humans, Mosaicism, Neurons, In Situ Hybridization, Fluorescence, Oxidative Stress, Patch-Clamp Techniques, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Synaptic Potentials, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review